Trevi Therapeutics Inc. (TRVI)

4.26

-0.26 (-5.75%)

At close: Mar 03, 2025, 3:59 PM

4.35

2.11%

After-hours: Mar 03, 2025, 07:29 PM EST

Trevi Therapeutics Cash Flow Statement

Table Mode

Year	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16
Net Income	-29.07M	-29.15M	-33.94M	-32.76M	-26.05M	-20.55M	-12.86M	-11.09M
Depreciation & Amortization	123K	43K	50K	47K	39K	23K	4K	4K
Stock-Based Compensation	2.25M	2.33M	2.54M	2.42M	1.13M	496K	205K	142.00
Other Working Capital	-2.8M	-1.24M	678K	641K	799K	-634K	630K	-421K
Other Non-Cash Items	-1.17M	-162K	974K	227K	215K	2.3M	2.6M	2.45M
Deferred Income Tax	n/a	n/a	-82K	9K	n/a	n/a	1.35M	n/a
Change in Working Capital	-3.85M	-1.23M	1.51M	1.06M	1.58M	-568K	722K	-1.49M
Operating Cash Flow	-31.71M	-28.18M	-28.95M	-29M	-23.09M	-18.29M	-7.97M	-11.19M
Capital Expenditures	-137K	-159K	n/a	-32K	-9K	-158K	-13K	n/a
Acquisitions	n/a	-829K	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	-9.93M	-126.22M	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	69.5M	19M	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	829K	n/a	-32K	-9K	n/a	n/a	n/a
Investing Cash Flow	59.43M	-107.37M	n/a	-32K	-9K	-158K	-13K	n/a
Debt Repayment	-9.41M	-5.83M	n/a	14M	n/a	-4.81M	-8.25M	8.6M
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	-1.53M	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	-2.24M	n/a	n/a	n/a
Other Financial Acitivies	-211K	11.73M	-408K	-415K	10.35M	9.98M	29.97M	n/a
Financial Cash Flow	-7.91M	111.31M	20.77M	16.72M	73.21K	3.63K	21.72M	8.6M
Net Cash Flow	19.81M	-24.24M	-8.17M	-12.31M	50.11M	-14.82M	13.73M	-2.6M
Free Cash Flow	-31.85M	-28.33M	-28.95M	-29.03M	-23.1M	-18.45M	-7.99M	-11.19M